10x Genomics has begun shipping Atera, a new spatial biology platform that combines whole transcriptome analysis, single-cell sensitivity, and large-scale capabilities. This platform removes previous limitations in spatial studies, enabling researchers worldwide to explore complex biological questions across diseases like cancer, neurodegeneration, and autoimmune disorders. Early adopters include leading institutes and biopharma companies, with plans to expand research applications and integrate AI-driven biological models. Future enhancements will add automation, multiomics, and mutation detection, promising to transform biological research and drug development.
10x Genomics (TXG) trades at USD 89.05 on Pluang as of Sep 29, 2026 20:11 WIB, showing a 1-day gain of 0.62%. The stock has a market cap of $11.53 billion and an enterprise value of $11.06 billion. Pluang users are almost evenly split in order activity, with 51% buying and 49% selling, reflecting balanced investor interest.
10x Genomics introduced Sentira Spatial Analysis, a new cloud platform that accelerates spatial biology data processing from hours to minutes using NVIDIA GPU acceleration. This innovation integrates data generation and analysis into one ecosystem, e...
Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...
